INDEMNIFICATION AGREEMENTIndemnification Agreement • September 29th, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 29th, 2017 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (“Agreement”) is made as of [●], 2017 by and between SPERO THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [●] (the “Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
CONFIDENTIAL TREATMENT REQUESTED STOCK PURCHASE AGREEMENT among SPERO CANTAB, INC., SPERO CANTAB UK LIMITED, SPERO THERAPEUTICS, LLC, PBB DISTRIBUTIONS LIMITED, NEW PHARMA LICENSE HOLDINGS LIMITED, CANTAB ANTI-INFECTIVES LTD, and PRO BONO BIO PLC...Confidential Treatment Requested • September 29th, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
Contract Type FiledSeptember 29th, 2017 Company Industry JurisdictionEach of the Milestone Payments shall be payable a maximum of one (1) time only even if achieved more than one (1) time with one or more Products. For the avoidance of doubt, (x) each of the Milestone Payments shall become payable upon the occurrence of the associated Milestone Event, irrespective of the order in which the Milestone Events occur relative to each other, and (y) no amounts shall be due for subsequent or repeated achievements of any Milestone Event.